Total Funding
52
46
Total FundingVenture - Series Unknown raised
Growth Score 52 in past quarter
-2 pts
Heat Score 46 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
121205
MetaModix manufactures surgical and medical instruments for the treatment of metabolic disease and Type II diabetes.
- Paul J. Thompson: Vice President of Research & Development
- Kedar R. Belhe: President and CEO
About the Company
MetaModix manufactures surgical and medical instruments for the treatment of metabolic diseases and Type II diabetes. The company's first product, the EndoSleeve, is designed to be a safer and more cost-effective treatment option for patients suffering from type 2 diabetes, NASH, and obesity.
It was founded in 2009 and is headquartered in
Plymouth, Minnesota, United States.